Friedman, Alan E.

Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous System

Bell, R. D., Sagare, A. P., Friedman, A. E., Bedi, G. S., Holtzman, D. M., Deane, R., & Zlokovic, B. V. (2007) · Journal of Cerebral Blood Flow & Metabolism

Alzheimer's disease research and treatmentsBarrier Structure and Function Studies

Cited by 670

A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer disease

Deane, R., Singh, I., Sagare, A. P., Bell, R. D., Ross, N. T., LaRue, B., Love, R., Perry, S., Paquette, N., Deane, R. J., et al. (2012) · Journal of Clinical Investigation

Alzheimer's disease research and treatmentsAdvanced Glycation End Products research

Cited by 619

The influence of protein adsorption on nanoparticle association with cultured endothelial cells

Ehrenberg, M. S., Friedman, A. E., Finkelstein, J. N., Oberdörster, G., & McGrath, J. L. (2009) · Biomaterials

Nanoparticle-Based Drug DeliveryPolymer Surface Interaction Studies

Cited by 412

SIRT1 protects against cigarette smoke-induced lung oxidative stress via a FOXO3-dependent mechanism

Yao, H., Sundar, I. K., Ahmad, T., Lerner, C., Gerloff, J., Friedman, A. E., Phipps, R. P., Sime, P. J., McBurney, M. W., Guarente, L., et al. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology

Sirtuins and Resveratrol in MedicineChronic Obstructive Pulmonary Disease (COPD) Research

Cited by 104

Chemical constituents involved in e-cigarette, or vaping product use-associated lung injury (EVALI)

Muthumalage, T., Friedman, M. R., McGraw, M. D., Friedman, A. E., & Rahman, I. (2020) · Toxics

Smoking Behavior and CessationForensic Toxicology and Drug Analysis

Cited by 82